氟伐他汀对充血性心力衰竭患者血清sICAM-1和sVCAM-1的影响被引量：3

Effects of fluvastatin on serum sICAM-1 and sVCAM-1 in patients with congestive heart failure

在线阅读下载PDF

导出

摘要目的:探讨氟伐他汀短期治疗对充血性心力衰竭(CHF)患者血清中可溶性细胞间黏附分子-1(sICAM-1)、可溶性血管细胞黏附分子-1(sVCAM-1)和肿瘤坏死因子α(TNF-α)水平的影响。方法:将97例CHF患者随机分为对照组(常规治疗组)和试药组(氟伐他汀组)。采用ELISA测定治疗前及治疗两周后血清中sICAM-1、sVCAM-1和TNF-α水平。结果:两种方法都可以明显降低血清sICAM-1、sVCAM-1和TNF-α水平(P<0.05);试药组血清TNF-α水平降低更为显著(P<0.05),但血清sICAM-1和sVCAM-1降低水平与对照组无显著差别。结论:在常规治疗基础上短期加用氟伐他汀治疗不能进一步降低CHF患者血清sICAM-1和sVCAM-1水平。 AIM： To observe the effects of short-term treatment of fluvastatin on serum soluble intercellular adhesion molecule-1 （slCAM-1）, soluble vascular cell adhesion molecule-1 （sVCAM-1） and tumor necrosis factor-α （TNF-α） in patients with congestive heart failure （CHF）. METHODS： Ninety seven patients with CHF were randomly divided into control group （conventional treatment group） and test drug group （fluvastatin group）. Levels of serum slCAM-1, sVCAM-1 and TNF-α were measured using enzyme-linked immunosorbent assay （ELISA） before treatment and after 2 weeks of treatment. RESULTS： Both methods can significantly reduce serum sICAM-1, sVCAM-1 and TNF-α level （P 〈 0. 05）. TNF-α levels of test drug groups reduced more significantly （ P 〈 0.05 ） , whereas decreased levels of serum slCAM-1 and sVCAM-1 had no significant difference compared with control group. CONCLUSION： On the basis of conventional treatment together with short-term fluvastatin treatment, no further reduction of the levels of sICAM-1 and sVCAM-1 were demonstrated.

作者李争马立庆朱卉黄喆吴云涛郑晓明

机构地区华北煤炭医学院附属中医医院心内科华北煤炭医学院附属开滦有限责任公司医院心内科

出处《心脏杂志》 CAS 2010年第3期408-411,共4页 Chinese Heart Journal

关键词心力衰竭充血性氟伐他汀细胞间黏附分子-1 血管细胞黏附分子-1 congestive heart failure fluvastatin intercellular adhesion molecule-1 vascular cell adhesion molecule-1

分类号 R541.6 [医药卫生—心血管疾病]

作者简介李争，主治医师，硕士Email：lizhengzhuhui@sina．com 通讯作者：郑晓明，主任医师，主要从事心力衰竭的临床研究Email：tszhuhui@sina．com

引文网络
相关文献

参考文献10

1Valgimigli M, Curello S, Ceconi C, et al. Neurohormones, cytokines and programmed cell death in heart failure: a new paradigm for the remodeling heart [J]. Cardiovasc Drugs Ther, 2001, 15 (6) :529 -537.
2Klein RM, Breuer R, Mundhenke M, et al. Circulating adhesion molecules ( slCAM-I,sVCAM-1 ) in patients with suspected inflammatory heart muscle disease[J]. Z Kardiol, 1998, 87(2) :84 -93.
3Noutsias M, Pauschinger M, Scbultheiss HP, et al. Cytotoxic perforin + and TIA-1 + infiltrates are associated with cell adhesion molecule expression in dilated cardiomyopathy [ J ]. Eur J Heart Fail, 2003, 5 (4) :469 - 479.
4Sato T, Suzuki H, Shibata M, et al. Tumor-necrosis-factor-alphagene-deficient mice have improved cardiac function through reduction of intercellular adhesion molecule-1 in myocardial infarction [J]. Circ J, 2006, 70(12) :1635 - 1642.
5Ao L, Song Y, Fullerton DA, et al. The interaction between myocardial depressant factors in endotoxemic cardiac dysfunction : role of TNF-alpha in TLR4-mediated ICAM-1 expression [ J ]. Cytokine, 2007, 38(3) :124 - 129.
6Mozaffarian D, Nye R, Levy WC. Statin therapy is associated with lower mortality among patients with severe heart failure[ J]. Am J Cardiol, 2004, 93(9) :1124 - 1129.
7Tousoulis D, Antoniades C, Bosinakou E, et al, Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure [ J ]. Atherosclerosis, 2005, 178 ( 2 ) : 359 - 363.
8Nawawi H, Osman NS, Annuar R, et al. Soluble intercellular adhesion molecule-1 and interleukin-6 level reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin [ J ]. Atherosclerosis, 2003, 169 ( 2 ) :283 - 291.
9庞文跃,姜立清,胡大一.阿托伐他汀对人内皮细胞间粘附分子-1表达的影响[J].中国医药导刊,2005,7(4):295-297. 被引量：7
10Bleske BE, Nicklas JM, Bard RL, et al. Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic eardiomyopathy and average low-density lipoprotein level [ J]. J Am Coll Cardiol, 2006, 47 (2) :338 -341.

二级参考文献7

1Yuan Y, Verna LK, Wang NP, et al. Cholesterol enrichment upregulates intercellar adhesion molecule - 1 in human vascular endothelial cell. Biochem Biophys Acta, 2001; 1534:139 - 148
2Springer TA. Adhesion receptors of the immune system. Nature,1990; 346: 425 - 434
3Vallance P, Bhagat K. Infection, inflammation and infarc - tion: does acute endothelial dysfunction provide a link? Lancet, 1997; 349:1391- 1392
4Shiraz, Iran. Statins: novel additions to the dermatologic arsenal? Exp Dermatol, 2004; 13(6) :337- 339
5Nawawi H, Osman NS, Annuar R, et al. Soluble intercellular adhesion molecule- 1 and interleukin - 6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin. Atherosclerosis, 2003; 169(2): 283-291
6Liu SF, Ye X, Malik AB. Inhibition of NF - kappaB activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes. Circulation, 1999; 100:1330 - 1337
7Wójciak - Stothard B, Williams L, Ridley AJ. Monocyte adhesion on rho - regulated receptor clustering. J Cell Biol, 1999; 145:1239- 1307